Background: Chronic Multi-symptom Illness (CMI) is an idiopathic condition that can cause severe disability in U.S. Veterans. Objectives: 1. The collection of data to assist in the development of a hypothesis that describes the pathophysiology of CMI and related conditions including Gulf War Illness and Chronic Fatigue Syndrome. 2. Development of a better understanding of the consequences of this syndrome on the study subjects impaired level of functioning. Design: This is an observational VA Pilot study of a cohort of 40 US Veterans with Chronic Multi-symptom illness studied between 2019 and 2025. Methods: The study population was drawn from U.S. veterans who receive medical care from the W.G. Hefner VA Health Care System in Salisbury, N.C. U.S. veterans were initially referred to the Rehabilitation Medicine Service (RMS) for various diagnoses associated with chronic or persistent pain. From this pool of RMS patients, 36 males and 4 females who were diagnosed with Chronic Multi-symptom Illness and who met the study inclusion criteria were selected to participate in the study. Data collected from this study group included: demographic, medical history, and physical symptom information, psychological and cognitive evaluation and testing data, physical exam results, and serum lab test data. Lab tests were performed twice on the study subjects. Lab tests included serum active vitamin D precursor, 25(OH)D3, levels, calcium levels, and human IgM and IgG antibody levels to dUTPase enzymes from three latent herpetic viruses, Varicella Zoster virus (VZV), Human Herpes 6 virus (HH6V), and Epstein Barr virus (EBV). Serum active vitamin D precursor levels were examined because active vitamin D has a role in immune system function including the suppression of latent viruses and the modulation (attenuation) of the immune system’s inflammatory response to microbials including latent viruses. The herpesvirus dUTPases from EBV, HH6V, and VZV are proteins/enzymes in viral DNA replication but not structural components of the mature virion. In this pilot study, antibodies against these proteins were used as biomarkers for abortive lytic replication, a process that can stimulate an inflammatory immune process. This abortive lytic inflammatory process is hypothesized to be distinct from the inflammatory response associated with full lytic viral reactivation, which results in the production of complete virions. Results: Demographic Data – 75% of study subject men and 50 % of women served in combat. Comparison of our pilot study population to the general VA population revealed differences: US Marines made up 25% of our study population versus 9.9% in the general VA population, and African American/Black study subjects made up 30% or our study population verses 15% in the VA general population. Our study subjects had high service connected, disability/ compensation ratings: 55% or 22/40 had a rating of greater than or equal to 80%, and 22.5% or 9/40 had a rating of greater than or equal to 100%. Neurological findings in study subjects included hyperalgesia to pin prick over the skin, which was present in 95% of study subjects, tinnitus (ringing in the ears) in 82% of study subjects, decreased balance on heel to toe walking which was normal in only 28.9% of study subjects with their eyes open and in only 2.7% with eyes closed. This test could not be performed in 18.4% with eyes open and in 40.5% with their eyes closed. Two study subjects developed severe quadriparesis and idiopathic neurocognitive disorders later in the study after their initial interview, physical exam, cognitive testing and blood tests were performed. Serum Lab Tests: Vitamin D, 25(OH)D3 Levels: in Trial 1 – Deficient range 11/40 (27.5%), Insufficient range 17/40 (42.5%) in Trial 2 – Deficient range 8/36 (22.2%), Insufficient range 11/36 (30.6%) Note: Only two study subjects were deficient for both seasonally adjusted 25(OH)D3 levels checked in Trials 1&2 Human IgG antibody levels to Herpesvirus dUTPase proteins: Trial 1 serum test results for human IgG serum antibody levels to herpes virus dUTPase proteins were negative for all three viruses tested in 10/40 (25%) of study subjects and positive for all three viruses examined in 7/40 (17.5%) of study subjects. Trial 2 serum test results for human IgG antibody levels to herpes virus dUTPase enzymes were negative for all three viruses tested in only 1/36 (2.8%) study subjects. Human IgG dUTPase antibodies were positive for all three viruses in 17/36 (47%) study subjects. In Trial 1 – Human VZV IgG was Pos. (elevated) for VZV dUTPase in 11/40 (12.5%) of study subjects, In Trial 2 – Human VZV IgG was Pos. (elevated) for VZV dUTPases in 23/36 (64%) of study subjects.